Development and validation of an artificial intelligence model for predicting post-transplant hepatocellular cancer recurrence.

Lai, Quirino;De Stefano, Carmine;Emond, Jean;Bhangui, Prashant;EurHeCaLT and the West-East LT Study Group;et.al.
(2023) Cancer communications (London, England) — Vol. 43, n° 12, p. 1381-1385 (2023)

Files

2023_Lai_Cancer_Commun.pdf
  • Open Access
  • Adobe PDF
  • 153.36 KB
  • https://creativecommons.org/licenses/by-nc-nd/4.0/

Details

Authors
  • Lai, Quirinoorcid-logo
    Author
  • De Stefano, Carmine
    Author
  • Emond, Jean
    Author
  • Bhangui, Prashant
    Author
  • Lerut, Jan PaulUCLouvain
    Author
  • EurHeCaLT and the West-East LT Study Group
    Collaborator
Show more
Abstract
DEAR EDITOR, In recent years, criteria based on the combination of morphology and biology have been proposed for improving the selection of hepatocellular cancer (HCC) patients waiting for liver transplantation (LT). Since all the proposed models showed suboptimal results in predicting the risk of post-LT recurrence, a prediction model constructed using artificial intelligence (AI) could be an attractive way to surpass this limit. Therefore, the Time_Radiological-response_Alpha-fetoproteIN_Artificial-Intelligence (TRAIN-AI) model was developed, combining morphology and biology tumor variables. [...]
Affiliations

Citations

Lai, Q., De Stefano, C., Emond, J., Bhangui, P., Ikegami, T., Schaefer, B., Hoppe-Lotichius, M., Mrzljak, A., Ito, T., Vivarelli, M., Tisone, G., Agnes, S., Ettorre, G. M., Rossi, M., Tsochatzis, E., Lo, C. M., Chen, C.-L., Cillo, U., Ravaioli, M., & Lerut, J. P. (2023). Development and validation of an artificial intelligence model for predicting post-transplant hepatocellular cancer recurrence. Cancer communications (London, England), 43(12), 1381-1385. https://doi.org/10.1002/cac2.12468 (Original work published 2023)